Use of oral contraceptives in infertile patients: A descriptive review

Gynecological Endocrinology

Volumn 22, Issue 10, 2006, Pages 537-546

  Palomba, Stefano ^a   Falbo, Angela ^a   Del Negro, Serena ^a   Russo, Tiziana ^a   Zullo, Fulvio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Assisted reproductive technologies; Infertility; Oral contraceptives; Ovulation induction; Sterility

Indexed keywords

AROMATASE INHIBITOR; CLOMIFENE CITRATE; FOLLITROPIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; GROWTH HORMONE; HUMAN MENOPAUSAL GONADOTROPIN; INSULIN SENSITIZING AGENT; ORAL CONTRACEPTIVE AGENT; RECOMBINANT FOLLITROPIN;

ASSISTED REPRODUCTIVE TECHNOLOGY; CLINICAL TRIAL; DESCRIPTIVE RESEARCH; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDICATION; DRUG MONITORING; DRUG RESPONSE; EMBRYO TRANSFER; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HEALTH CARE COST; HUMAN; INFERTILITY THERAPY; LOW DRUG DOSE; META ANALYSIS; OVARY CYST; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

ANOVULATION; CONTRACEPTIVES, ORAL; FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY; OVULATION INDUCTION;

EID: 33845366866     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590601005672     Document Type: Review

References (79)

1. Baird DT. Overview of advances in contraception. Br Med Bull 2000;56:704-716.
2. Lee R. The demographic transition. Three centuries fundamental change. J Econ Perspect 2003;17:167-190.
3. The ESHRE Capri Workshop Group. Noncontraceptive health benefits of combined oral contraception. Hum Reprod Update 2005;11:513-525.
4. Shearman RP. Progress in the investigation and treatment of anovulation. Am J Obstet Gynecol 1969;103:444-463.
5. Whitelaw MJ. The myth of oral contraceptives in the treatment of infertility. Fertil Steril 1968;19:372-375.
6. Genazzani AD, Battaglia C, Gamba O, Petraglia F, Malavasi B, Genazzani AR. The use of a combined regimen of GnRH agonist plus a low-dose oral contraceptive improves the spontaneous pulsatile LH secretory characteristics in patients with polycystic ovary disease after discontinuation of treatment. J Assist Reprod Genet 2000;17:269-275.
7. Templeton A, van Look P, Lumsden MA, Angell R, Aitken J, Duncan AW, Baird DT. The recovery of pre-ovulatory oocytes using a fixed schedule of ovulation induction and follicle aspiration. Br J Obstet Gynaecol 1984;91:148-154.
8. Gonen Y, Jacobson W, Casper RF. Gonadotropin suppression with oral contraceptives before in vitro fertilization. Fertil Steril 1990;53:282-287.
9. Al-Mizyen E, Sabatini L, Lower AM, Wilson CM, Al-Shawaf T, Grudzinskas JG. Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET? J Assist Reprod Genet 2000;17:140-146.
10. Damario MA, Barmat L, Liu HC, Davis OK, Rosenwaks Z. Dual suppression with oral contraceptives and gonadotropin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients. Hum Reprod 1997;12:2359-2365.
11. Biljan MM, Mahutte NG, Dean N, Hemmings R, Bissonnette F, Tan SL. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues. J Assist Reprod Genet 1998;15:599-604.
12. Biljan MM, Mahutte NG, Dean N, Hemmings R, Bissonnette F, Tan SL. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil Steril 1998;70:1063-1069.
13. Fischl F, Huber JC, Obruca A. Zeitliche optimierung der kontrollierten hyperstimulation (KOH) in kombination mit GnRH-antagonisten und ovulationshemmer in einem IVF-programm. J Fertil Reprod 2001;11:50-51.
14. Cedrin-Durnerin I, Grange-Dujardin D, Laffy A, Parneix I, Massin N, Galey J, Theron L, Wolf JP, Conord C, Clement P, et al. Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study. Hum Reprod 2004;19:1979-1984.
15. Barmat LI, Chantilis SJ, Hurst BS, Dickey RP. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization. Fertil Steril 2005;83:321-330.
16. Shapiro DB, Mitchell-Leef D, Carter M, Nagy ZP. Ganirelix acetate use in normal- and poor-prognosis patients and the impact of estradiol patterns. Fertil Steril 2005;83:666-670.
17. Rombauts L, Healy D, Norman RJ. Orgalutran Scheduling Study Group. A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients. Hum Reprod 2006;21:95-103.
18. Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. Hum Reprod 2006;21:352-357.
19. Branigan EF, Estes MA. Treatment of chronic anovulation resistant to clomiphene citrate (CC) by using oral contraceptive ovarian suppression followed by repeat CC treatment. Fertil Steril 1999;71:544-546.
20. Branigan EF, Estes MA. A randomized clinical trial of treatment of clomiphene citrate-resistant anovulation with the use of oral contraceptive pill suppression and repeat clomiphene citrate treatment. Am J Obstet Gynecol 2003;188:1424-1428.
21. Elkind-Hirsch KE, Webster BW, Brown CP, Vernon MW. Concurrent ganirelix and follitropin β therapy is an effective and safe regimen for ovulation induction in women with polycystic ovary syndrome. Fertil Steril 2003;79:603-607.
22. Copperman AB. Antagonists in poor-responder patients. Fertil Steril 2003;80:S16-S24, discussion S32-S34.
23. Branigan EF, Estes MA. Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression. Fertil Steril 2000;73:587-590.
24. Owen EJ, Shoham Z, Mason BA, Ostergaard H, Jacobs HS. Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertil Steril 1991;56:1104-1110.
25. Scott RT, Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 1994;61:880-885.
26. Lindheim SR, Barad DH, Witt B, Ditkoff E, Sauer MV. Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation. J Assist Reprod Genet 1996;13:745-747.
27. Schoolcraft W, Schlenker T, Gee M, Stevens J, Wagley L. Improved controlled ovarian hyperstimulation in poor responder in in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol. Fertil Steril 1997;67:93-97.
28. Fukuda M, Fukuda K, Yding Andersen C, Byskov AG. Does anovulation induced by oral contraceptives favor pregnancy during the following two menstrual cycles? Fertil Steril 2000;73:742-747.
29. Kovacs P, Barg PE, Witt BR. Hypothalamic-pituitary suppression with oral contraceptive pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles. J Assist Reprod Genet 2001;18:391-394.
30. Swain I. Prolonged oral contraception and its after-effects. Med J Aust 1968;1:426.
31. Ostergaard E. Oral anticonception. Side effects and risks. Acta Obstet Gynecol Scand 1969;48:57-72.
32. Janerich DT, Lawrence CE, Jacobson HI. Fertility patterns after discontinuation of use of oral contraceptives. Lancet 1976;1:1051-1053.
33. Kovacs I. Examination of the rebound effect of biphasic oral contraceptives. Ther Hung 1990;38:110-113.
34. Jernstrom H, Knutsson M, Olsson H. Temporary increase of FSH levels in healthy, nulliparous, young women after cessation of low-dose oral contraceptive use. Contraception 1995;52:51-56.
35. Fukuda M, Katayama K, Tojo S. Inhibitory effect of progesterone on follicular growth and induced superovulation in the rat. Arch Gynecol 1980;230:77-87.
36. Fukuda M, Fukuda K, Yding Andersen C, Byskov AG. Does corpus luteum locally affect follicular growth negatively? Hum Reprod 1997;12:1024-1027.
37. Akahori T. The effect of follicular maturation and sex steroids upon LH and FSH binding to porcine granulosa cells. Acta Obstet Gynecol Jpn 1978;30:191-198.
38. Schreiber JR, Nakamura K, Truscello AM, Erickson GF. Progestins inhibit FSH-induced functional LH receptors in cultured rat granulosa cells. Mol Cell Endocrinol 1982;25:113-124.
39. Beck JI, Boothroyd C, Proctor M, Farquhar C, Hughes E. Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database Syst Rev 2005;(1):CD002249.
40. Palomba S, Orio F Jr, Russo T, Falbo A, Cascella T, Colao A, Lombardi G, Zullo F. Is ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome? J Endocrinol Invest 2004;27:796-805.
41. Fluker MR, Wang IY, Rowe TC. An extended 10-day course of clomiphene citrate (CC) in women with CC-resistant ovulatory disorders. Fertil Steril 1996;66:761-764.
42. Palomba S, Falbo A, Russo T, Zullo F. Ovulation induction in anovulatory patients with polycystic ovary syndrome. Curr Drug Ther 2006;1:23-29.
43. Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de Koppel P, Collins JA. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888-896.
44. Tan SL, Royston P, Campbell S, Jacobs HS, Betts J, Mason B, Edwards RG. Cumulative conception and live birth rates after in-vitro fertilisation. Lancet 1992;339:1390-1394.
45. Tan SL, Maconochie N, Doyle P, Campbell S, Balen A, Bekir J, Brinsden P, Edwards RG, Jacobs HS. Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Am J Obstet Gynecol 1994;171:513-520.
46. Ron-El R, Herman A, Golan A, Raziel A, Soffer Y, Caspi E. Follicle cyst formation following long-acting gonadotropin-releasing hormone analog administration. Fertil Steril 1989;52:1063-1066.
47. Rizk B, Tan SL, Kingsland C, Steer C, Mason BA, Campbell S. Ovarian cyst aspiration and the outcome of in vitro fertilization. Fertil Steril 1990;54:661-664.
48. Jenkins JM, Davies DW, Anthony F, Wood P, Gadd SG, Watson RH, Masson GM. The detrimental influence of functional ovarian cysts during in-vitro fertilization cycles. Hum Reprod 1992;7:776-780.
49. Jenkins JM, Anthony FW, Wood P, Rushen D, Masson GM, Thomas E. The development of functional ovarian cysts during pituitary down-regulation. Hum Reprod 1993;8:1623-1627.
50. Olivennes F, Cunha-Filho JS, Fanchin R, Bouchard P, Frydman R. The use of GnRH antagonists in ovarian stimulation. Hum Reprod Update 2002;8:279-290.
51. Tarlatzis BC, Bili HN. Gonadotropin-releasing hormone antagonists: impact of IVF practice and potential non-assisted reproductive technology applications. Curr Opin Obstet Gynecol 2003;15:259-264.
52. Ledger WL. Patient scheduling for gonadotropin-releasing hormone antagonist protocols. Hum Fertil (Camb) 2002;5:G29-G32.
53. Doody NJ, Langley M, Marek D, Doody K. Oral contraceptives pre-treatment for IVF cycles employing recombinant FSH and a GnRH antagonist. Fertil Steril 2001;76:S236.
54. Van Loenen ACD, Pirard C, Donnez J, Huirne AF, Schats R, Lambalk CB. Recombinant follicle stimulating hormone (R-FSH) versus recombinant luteinizing hormone (R-LH) and R-FSH treatment in combination with cetrorelix after oral contraceptive programming in IVF/ICSI: a feasibility study. Fertil Steril 2002;78:S46.
55. Filicori M, Cognigni GE, Samara A, Filicori M, Cognigni GE, Samara A, Melappioni S, Perri T, Cantelli B, Parmegiani L, et al. The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction. Hum Reprod Update 2002;8:543-557.
56. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, de Fatis CT, Pocognoli P. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J Clin Endocrinol Metab 1999;84:2659-2663.
57. Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC, Devroey P. Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 2004;82:102-107.
58. Foulot H, Ranoux C, Dubuisson JB, Rambaud D, Aubriot FX, Poirot C. In vitro fertilization without ovarian stimulation: a simplified protocol applied in 80 cycles. Fertil Steril 1989;52:617-621.
59. Paulson RJ, Sauer MV, Lobo RA. In vitro fertilization in unstimulated cycles: a new application. Fertil Steril 1989;51:1059-1060.
60. Paulson RJ, Sauer MV, Francis MM, Macaso TM, Lobo RA. In vitro fertilization in unstimulated cycles: the University of Southern California experience. Fertil Steril 1992;57:290-293.
61. Paulson RJ, Sauer MV, Francis MM, Macaso T, Lobo RA. Factors affecting pregnancy success of human in-vitro fertilization in unstimulated cycles. Hum Reprod 1994;9:1571-1575.
62. Jones HW Jr, Jones GS, Andrews MC, Acosta A, Bundren C, Garcia J, Sandow B, Veeck L, Wilkes C, Witmyer J, et al. The program for in vitro fertilization at Norfolk. Fertil Steril 1982;38:14-21.
63. Van Rysselberge M, Puissant F, Barlow P, Lejeune B, Delvigne A, Leroy F. Fertility prognosis in IVF treatment of patients with cancelled cycles. Hum Reprod 1989;4:663-666.
64. Nargund G, Cheng WC, Parson J. The impact of ovarian cystectomy on ovarian response to stimulation during in vitro fertilization cycles. Hum Reprod 1995;11:81-83.
65. Manzi DL, Thornton KL, Scott LB, Nulsen JC. The value of increasing the dose of human menopausal gonadotropins in women who initially demonstrate a poor response. Fertil Steril 1994;62:251-256.
66. Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51:651-654.
67. Toner JP, Philput CB, Jones GS, Muasher SJ. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784-791.
68. Navot D, Rosenwaks Z, Margalioth EJ. Prognostic assessment of female fecundity. Lancet 1987;2:645-647.
69. Loumaye E, Billion JM, Mine JM, Psalti I, Pensis M, Thomas K. Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril 1990;53:295-301.
70. Garcia JE, Padilla SL, Bayati J, Baramki TA. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization. Fertil Steril 1990;53:302-305.
71. Halvorson LM, DeCherney AH. Inhibin, activin, and follistatin in reproductive medicine. Fertil Steril 1996;65:459-469.
72. Syrop CH, Willhoite A, Van Voorhis BJ. Ovarian volume: a novel outcome predictor for assisted reproduction. Fertil Steril 1995;64:1167-1171.
73. Tomas C, Nuojua-Huttunen S, Martikainen H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum Reprod 1997;12:220-223.
74. Lass A, Silye R, Abrams DC, Krausz T, Hovatta O, Margara R, Winston RM. Follicular density in ovarian biopsy of infertile women: a novel method to assess ovarian reserve. Hum Reprod 1997;12:1028-1031.
75. Keay SD, Liversedge NH, Mathur RS, Jenkins JM. Assisted conception following poor ovarian response to gonadotropin stimulation. Br J Obstet Gynaecol 1997;104:521-527.
76. Tarlatzis BC, Zepiridis L, Grimbis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update 2003;9:61-76.
77. Check JH, Nowroozi K, Chase JS, Nazari A, Shapse D, Vaze M. Ovulation induction and pregnancies in 100 consecutive women with hypergonadotropic amenorrhea. Fertil Steril 1990;53:811-816.
78. Ibrahim ZH, Matson PL, Buck P, Lieberman BA. The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response. Fertil Steril 1991;55:202-204.
79. Bergh C, Hillensjo T, Wikland M, Nilsson L, Borg G, Hamberger L. Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertil Steril 1994;62:113-120.